Glucagon-Like Peptide-1 Receptor Agonists and Risk of Uveitis
This cohort study found that GLP-1RA prescriptions were associated with a lower risk of uveitis compared with controls. These findings suggest potential anti-inflammatory benefits beyond glycemic control, warranting further investigation into their role in ocular inflammatory diseases.
Authors
- Sumit Sharma (ORCID: https://orcid.org/0000-0001-5769-0717)
- Matthew Schulgit (ORCID: https://orcid.org/0009-0002-4056-6706)
- Amy S. Nowacki (ORCID: https://orcid.org/0000-0002-1216-1448)
- Nitesh Mohan (ORCID: https://orcid.org/0000-0001-6929-9504)
- Sunil K. Srivastava (ORCID: https://orcid.org/0000-0002-0398-8806)
- David C. Kaelber (ORCID: https://orcid.org/0000-0001-7855-9515)
Institutions
- MetroHealth (US)
- Cleveland Clinic (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Cleveland Eye Clinic (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- JAMA Ophthalmology
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1001/jamaophthalmol.2025.2822
- Citations
- 5
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 8.54